1 / 25

A few inborn errors

A few inborn errors. Bruce R. Wall, MD, FACP October 10, 2005. Contents:. Von Hippel-Landau disease Alport’s syndrome (hereditary nephritis) Fabry’s disease Sturge Weber disease Tuberous sclerosis AD-PCKD Too much… Brief mystery case. Baseball season: famous quotes.

dpiggott
Download Presentation

A few inborn errors

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A few inborn errors Bruce R. Wall, MD, FACP October 10, 2005

  2. Contents: • Von Hippel-Landau disease • Alport’s syndrome (hereditary nephritis) • Fabry’s disease • Sturge Weber disease • Tuberous sclerosis • AD-PCKD • Too much… • Brief mystery case

  3. Baseball season: famous quotes • “It ain’t about the heat, it’s the humility” • “He hits from both sides of the plate. He’s amphibious.” • “Baseball is 90% mental. The other half is physical.” Yogi Berra

  4. More baseball quotes • “I never questioned the integrity of an umpire… their eyesight, yes…” Leo Durocher • “About the only problem with success is that is does not teach you how to deal with failure” Tommy Lasorda • “I think the good Lord is a Yankee” Mariano Rivera • “You can only milk a cow so long, then you’re left holding the pail” Hank Aaron, retirement party 1976

  5. Recent admission • 60 yo WM with known von Hippel Landau • Previous native nephrectomy for RCC • Progressive CKD related to diabetes • Previous CNS screen (CT scan) negative for hemangioblastoma • No sign of episodic hypertension/pheo • No recent imaging of remaining kidney • Does he need bilateral nephrectomy??

  6. History • 1894: Von Hippel, German opthalmologist, recognized familial nature of retinal hemangioblastoma • 1896: Arvid Landau, Swedish opthalmologist, added cerebellar and retinal hemorrhages – “angiomatosis of the central nervous system” • (noted renal and pancreatic involvement) • 1964: landmark paper from Melmon and Rose codified term VHL disease

  7. Clinical features of VHL • Inherited autosomal dominant syndrome with a variety of benign and malignant tumors • 1 in 36,000 newborns • Hemangioblastomas, including retinal angiomas • Clear cell renal cell carcinomas (RCCs) • Pheochromocytoma • Endolymphatic sac tumor of the middle ear • Serous cystadenomas/neuroendocrine tumor of pancreas • Papillary cystadenomas of epididymis/broad ligament • Median actuarial survival was 49yrs; death from RCCs • Type I do not develop pheochromocytoma • Type II do have pheochromocytoma, +/- RCCs

  8. Molecular pathogenesis of VHL • “Two hit model” with germline mutation that inactivates one copy of VHL gene in all cells • Gene whose normal function is regulate cell growth • Disease occurs with loss of expression of the second (normal allele) from either somatic mutation or hypermethylation of its promoter • VHL gene has been mapped to chromosome 3p25 and cloned • Gene product, pVHL, functions as tumor suppressor protein

  9. Improving survival in VHL • Improved understanding of natural history of VHL-associated tumors • Surveillance strategies have led to detection of small asymptomatic tumors, prior to metastatic disease • Renal-sparing surgery in RCC decreases ESRD

  10. Hemangioblastoma • Most common lesion; 60-85% of VHL pts; mean diagnosis @ 29yrs of age • Conversely - among pts with HemangioB - 25% have VHL and 75% cases are sporadic • Well-circumscribed, capillary rich benign neoplasm cause pressure via hemorrhage • Opthalmoscopy + fluorescein angiograpy (not CT) • In VHL pts, HemangioB tend to be infratentorial and multiple (160pts: total of 655 tumors, including spinal cord, cerebellum and brain stem) • Management: can be dormant, unpredictable, +/- phases of accelerated growth • Stereotactic radiosurgery plus conventional radiation play a role in lesions not accessible to surgery

  11. Retinal angiomas • Hemangioblastomas that develop in the retina or optic nerve • Affect 60% of VHL patients, often multifocal, and bilateral • Untreated causes hemorrhage, detachment, and loss of vision • VHL pts are younger (age 18), average 4 tumors • Laser photocoagulation and cryotherapy are effective > 70% (except optic nerve) • XRT may have a role for salvage; VEGF receptor inhibitors are being studied

  12. Renal cell carcinoma • 60% VHL pts develop multiple cysts & RCC • All VHL RCC are clear cell tumors (not papillary, chromophobe, or oncocytic histology) • Mean age of onset 44 years; 70% of patients surviving to age 60 • Multicentric, bilateral, not restricted to cysts • Therapeutic approach to VHL-associated RCC has shifted from radical nephrectomy to renal sparing surgery

  13. Renal sparing approach • Improved imaging modalities: CT, MRI, US • Solid renal tumors < 3cm have low metastatic potential, and can be monitored • Partial nephrectomy as effective as total nephrectomy for early RCC • Laparoscopic cryoablation or radioablation in patients with mulitple or bilateral tumors • 85% develop new renal tumors by 10yrs (LC) • Transplantation in VHL post bilat nephrectomy is ok; no increased ‘tumorogenesis’ despite meds

  14. Pheochromocytoma • Pheo can be sporadic in VHL, MEN 2, neurofibromatosis 1, succinate DeHYase Def • For VHL type II is subdivided based upon risk of RCC: Type IIA and IIB : low and high% of RCC • Type IIC have pheochromocytoma without RCC • Pheochromocytoma in VHL occur in younger pts, mulitple, extraadrenal, less sxs, difficult to Dx • NIH study: 64pts = 106 tumors; 12% extraadrenal • Mayo : 109pts = 20 tumors; 15% extraadrenal 33% failed evidence of catecholamine production

  15. Endolymphatic sac tumors of the middle ear • Papillary cystadenomas are highly vascular lesion within middle ear • Occur at younger age; often bilateral • Common symptoms: hearing loss, tinnitus, vertigo, and facial muscle weakness • Generally slow growth rate; primary therapy is surgical • Radiosurgery may have a role

  16. Pancreatic tumors • Common in pts with VHL • Multicenter study of 158 pts: 77% pancreatic lesions – cysts, adenomas, neuroendocrine tumors • Mostly asymptomatic, rarely pancreatitis • Neuroendocrine tumors can metastasize and produce secreted peptides (VIP,insulin) • Surgery is primary form of therapy

  17. Papillary cystadenomas of epididymis or broad ligament • Single epididymal cyst is common in general population (does not mean pt has VHL) • Bilateral epididymal cysts are almost pathognomonic of VHL • No treatment is required • In women, symptoms may include pain and menorrhagia

  18. Diagnosis: autosomal dominant disease • Clinical Dx based on finding TWO VHL-associated tumors • Genetic testing (DNA sequencing and quantitative Southern blot of VHL gene): 100% sensitive and specific • Germline mutations in VHL gene can be inherited or present de novo (20% of VHL kindreds) • Somatic mosaics: mutation occurs during embryonic development after fertilization; pt may present with classic VHL, yet mutation may not be detectable in peripheral blood (risk of transmission to children < 50%) • Counseling: VHL family Alliance (www.vhl.org)

  19. Surveillance protocols: • Infants and children < age 11: annual retinal exam and plasma catecholamines • Adolescents > age 11: Plasma catecholamines and abd CT with contrast plus retinal exam plus MRI brain and spine with gadolinium • Adults: catecholamines, abd CT, retinal exam, MRI of CNS, MRI of kidneys, baseline ENT exam with audiometry

  20. Genetics of PCKD: “nice gene” • Occurring in 1 in every 400 to 1000 births • < 50% will be diagnosed (clinically silent) • Most families abnormal chromosome 16 (called PKD1 locus) • Other gene is on chromosome 4 (PKD2 locus) • PKD1 96% of North America; 85% of Europe • Both encode proteins AKA “polycystin I & II” • PKD1 gene is adjacent to gene of Tuberous sclerosis (TSC2), associated with cyst formation (angiomyolipoma) • Genotype/phenotype correlation with PKD1 & 2 “unclear”

  21. Polycystin 1 • Localized in renal tubular epithelia, hepatic ductules, pancreatic ducts (all sites in PCKD) • Integral membrane protein • Less abundant in adult than fetal epithelia • Overexpressed in most cysts in kidney from PCKD patients • Cause abnormalities in renal cilia • Induce cell cycle arrest • Why is there variable phenotypic expression? • Defect is present in 100% of cells, yet only 10% of tubules form cysts… (second hit hypothesis?) • Therefore – mechanism of cyst formation and growth is unclear (abnormal differentiation or cell maturation)

  22. Diagnosis and screening for PCKD • Easy diagnosis in overt disease: flank pain, positive family history, CRI, large kidneys with multiple bilateral cysts on CT or sono • Cysts in liver, pancreas, and spleen • What do you do with otherwise unexplained CRI, hematuria, with negative family hx? • Acquired cystic disease of the kidney

  23. Mystery case • 18 yo WF noted to have minimal proteinuria and microscopic hematuria @ 3rd trimester • Abnormal urinalysis persisted post delivery • 24 hour urine protein 800mg per day; GFR estimation of 90ml/hr • During 2nd pregnancy at age 25 yrs: abn UA with 1200mg proteinuria with creatinine clearance of 82ml/hr • Negative serology for hepatitis B, lues, SLE, myeloma, Wegener’s, and VHL… • Diagnostic test was performed

  24. Thin basement membrane diseaese • Benign familial hematuria – relatively common (autosomal dominant inheritance) • GBM decreased to 150-225nM vs 400nM • Along with IGA – common cause of asymptomatic hematuria • Heterozygous defect in COL4A3 or A4 (alpha-4 chains of type IV collagen) • Discovered via work up of microscopic hematuria (normal urine protein, BP, GFR) • Rare episodes of gross hematuria and flank pain from hypercalciuria or hyperuricosuria rather than GBM changes • Since GFR is usually normal, renal biopsy not done

  25. Thin basement membrane disease • Hematuria represents and exaggeration of the normal process of naturally occurring leaks in the GBM • No extra renal manifestations: hearing loss, ocular abnormalities • Early renal biopsy difficult to distinguish from hereditary nephritis • Screen first degree relatives (autos dominant inheritance) – look for father to son inheritance, which is not seen in X linked nephritis (alport’s) • Rarely may lead to progressive CKD (?FSGN)

More Related